Cart
sales@molnova.com
4-Hydroxy-3-methoxybenzylamine hydrochloride
CAS No. 7149-10-2
4-Hydroxy-3-methoxybenzylamine hydrochloride( —— )
Catalog No. M15732 CAS No. 7149-10-2
Vanillylamine is an alkaloid that is an intermediate in the biosynthesis of capsaicin. Vanillylamine is produced from vanillin by the enzyme vanillin aminotransferase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | In Stock |
|
| 10MG | 45 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 98 | In Stock |
|
| 100MG | 129 | In Stock |
|
| 200MG | 181 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Hydroxy-3-methoxybenzylamine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionVanillylamine is an alkaloid that is an intermediate in the biosynthesis of capsaicin. Vanillylamine is produced from vanillin by the enzyme vanillin aminotransferase.
-
DescriptionVanillylamine is an alkaloid that is an intermediate in the biosynthesis of capsaicin. Vanillylamine is produced from vanillin by the enzyme vanillin aminotransferase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number7149-10-2
-
Formula Weight189.64
-
Molecular FormulaC8H12ClNO2
-
Purity>98% (HPLC)
-
SolubilitySoluble in Ethanol
-
SMILESCl.COC1=C(O)C=CC(CN)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Peptide YY (canine, ...
Peptide YY (pig) is a 36 amino acid gastrointestinal peptide, can be isolated from porcine duodenum. Peptide YY (pig) decreases appetite and food-intake by activation of the Y2 receptor. Peptide YY (pig) is present mainly in pancreatic endocrine cells with effect on both intestinal motility and the cardiovascular system.
-
(D-Ala2)-β-Casomorph...
(D-Ala2)-β-Casomorphin (1-3) amide
-
Compound K
HIV-IN-11 is part of the hydroxylaminoglutaramide (HAPA) transition state isomeric series of HIV protease inhibitors and is a potent and selective inhibitor of HIV-1 protease. HIV-IN-11 competitively inhibits HIV-1 PR (Ki: 0.049 nM) and potently inhibits replication of HIV(IIIb)-infected MT4 lymphocytes at concentrations of 25.0-50.0 nM. HIV-IN-11 displays a longer half-life than indinavir sulfate in animal models and serves as a promising second-generation HIV protease inhibitor.
